Amber Pepper, MD
Allergy & Immunology · Tampa, FLNPI 1013259407
Payments from drug & device makers
Across 443 payments — averaging $1315.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$304K
- Novartis$188K
- Pfizer$40K
- UCB SA$29K
- Gilead$17K
- AstraZeneca$999
- plus $4K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 169 | $304,272 |
| Novartis | 41 | $188,361 |
| Pfizer | 28 | $39,571 |
| UCB SA | 5 | $29,021 |
| Gilead | 1 | $16,500 |
| AstraZeneca | 46 | $999 |
| GSK | 32 | $624 |
| CSL Behring | 26 | $516 |
| Regeneron Healthcare Solutions, Inc. | 14 | $476 |
| Sanofi | 11 | $450 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $263 |
| Pharming Healthcare, Inc. | 8 | $163 |
| Genentech USA, Inc. | 6 | $157 |
| Arcutis Biotherapeutics, Inc. | 1 | $105 |
| Amgen | 5 | $98 |
| Grifols USA, LLC | 5 | $97 |
| Sanofi-aventis U.S. LLC | 1 | $92 |
| Genentech, Inc. | 1 | $84 |
| Covis Pharma GmbH | 4 | $77 |
| Lilly USA, LLC | 2 | $63 |
| Incyte Corporation | 1 | $58 |
| Optinose US, Inc. | 3 | $52 |
| ADMA Biomanufacturing LLC | 2 | $45 |
| AbbVie | 2 | $43 |
| Shire North American Group Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $42 |
| GC Biopharma USA, Inc. | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Ionis Pharmaceuticals, Inc. | 2 | $35 |
| Greer Laboratories, Inc. | 1 | $30 |
| Kaleo, Inc. | 2 | $30 |
| Merck | 1 | $24 |
| LEO Pharma Inc. | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $18 |
| Alk-abello, Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $11 |
| Organon | 1 | $3 |
How this compares
$582,584 in reported general payments places this provider in the 90th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Tampa
- Thomas CasaleTampa$1.7M
- Dennis LedfordTampa$1.4M
- Seong ChoTampa$969K
- Juan Carlos CardetTampa$468K
- Mark GlaumTampa$337K
- Richard LockeyTampa$227K
- Farnaz TabatabaianTampa$76K
- Ammar HatabTampa$14K
- Jaime LandmanAventura$3.9M
- Ileana RodicioMiami$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.